Senomorphic Compound Efficacy refers to the measured effectiveness of specific therapeutic agents, known as senomorphics, in modulating the harmful characteristics of senescent cells without necessarily causing their death. These compounds aim to alter the Senescence-Associated Secretory Phenotype (SASP), which includes the secretion of pro-inflammatory cytokines, growth factors, and proteases. The goal is to mitigate the systemic, detrimental effects of aging cells on surrounding healthy tissue and the endocrine environment.
Origin
This term is a highly specialized concept originating from the emerging field of geroscience, combining “senomorphic” (modulating senescence) with “efficacy” (effectiveness). It is distinct from senolytics, which are compounds designed to kill senescent cells. This approach targets the paracrine signaling of senescent cells.
Mechanism
The mechanism of senomorphic compounds involves inhibiting the signaling pathways that drive the production and secretion of the SASP factors, such as NF-κB and p38 MAPK. By neutralizing the inflammatory and destructive signals emanating from senescent cells, these agents reduce chronic low-grade inflammation, improve tissue microenvironments, and potentially restore proper hormonal signaling, which is often impaired by systemic inflammation.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.